The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.28BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue (TTM)
58.37BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Profit Margin
-0.42%
vs Capital Markets peers
Updated Sep 27, 2026
Beta
3.68x
vs all stocks
Updated Sep 27, 2026
52-Week Change
-29.31%
vs all stocks
Updated Sep 27, 2026
Market Capitalization
14.28BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Enterprise Value
9.13BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Forward P/E
-71.15x
vs Capital Markets peers
Updated Sep 27, 2026
Price to Sales (TTM)
0.2447x
vs Capital Markets peers
Updated Sep 27, 2026
Price to Book (MRQ)
2.59x
vs Capital Markets peers
Updated Sep 27, 2026
Enterprise to Revenue
0.1560x
vs Capital Markets peers
Updated Sep 27, 2026
Enterprise to EBITDA
0.1610x
vs Capital Markets peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 14.92×.Updated Sep 27, 2026
Gross Margin
-0.11%
vs Capital Markets peers
Updated Sep 27, 2026
Profit Margin
-0.42%
vs Capital Markets peers
Updated Sep 27, 2026
Operating Margin
96.23%
vs Capital Markets peers
Updated Sep 27, 2026
Return on Assets (TTM)
356.48%
vs Capital Markets peers
Updated Sep 27, 2026
Return on Equity (TTM)
-10.41%
vs Capital Markets peers
Updated Sep 27, 2026
Revenue (TTM)
58.37BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Revenue per Share (TTM)
311.00USDUpdated Sep 27, 2026
Quarterly Revenue Growth
-3.80%
vs Capital Markets peers
Updated Sep 27, 2026
EBITDA (TTM)
611.88MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Net Income (TTM)
-86.30MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Operating Cash Flow (TTM)
-357.28MUSD
vs all stocks (USD)
Updated Sep 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 27, 2026
Payout Ratio
0.00%
vs Capital Markets peers
Updated Sep 27, 2026
Minority Interest (Equity)
1.08BUSDFY2025 · Dec 31, 2025
Revenue
60.41BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
60.52BUSDFY2025 · Dec 31, 2025
Gross Profit
-115.91MUSDFY2025 · Dec 31, 2025
Operating Income
575.11MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-270.68MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-29.33MUSDFY2025 · Dec 31, 2025
Net Income
-241.35MUSDFY2025 · Dec 31, 2025
EBIT
-211.43MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
611.88MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
257.92MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
-948.94MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
59.25MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-1.52USDFY2025 · Dec 31, 2025
EPS (Diluted)
-1.52USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
159.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
159.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-241.35MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-638.35MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-1.82BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.25BUSDFY2025 · Dec 31, 2025
Income Tax Paid
5.80MUSDFY2025 · Dec 31, 2025
Interest Paid
53.32MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-241.35MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
34.07MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
41.13MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
53.61MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-1.26BUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
25.20MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
706.29MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-1.18BUSDFY2025 · Dec 31, 2025
Net Acquisitions
-7.78MUSDFY2025 · Dec 31, 2025
Purchase of Investments
-2.65BUSDFY2025 · Dec 31, 2025
Sale of Investments
2.64BUSDFY2025 · Dec 31, 2025
Other Investing Activity
-96.52MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.29BUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
2.10BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-820.89MUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-440.57MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-51.40MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
-49.31MUSDFY2025 · Dec 31, 2025
Other Financing Charges
834.08MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.57BUSDFY2025 · Dec 31, 2025
Shares Outstanding
194.80MSharesUpdated Sep 27, 2026
Float Shares
190.29MSharesUpdated Sep 27, 2026
Shares Short
30.80MSharesUpdated Sep 27, 2026
Short Ratio
5.48days
vs all stocks
Updated Sep 27, 2026
Short % of Shares Outstanding
18.10%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 15.81%.Updated Sep 27, 2026
% Held by Insiders
2.27%
vs all stocks
Updated Sep 27, 2026
% Held by Institutions
83.87%
vs all stocks
Updated Sep 27, 2026
Total Cash (MRQ)
1.55BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Cash per Share (MRQ)
8.00USDUpdated Sep 27, 2026
Total Debt (MRQ)
5.08BUSD
vs all stocks (USD)
Updated Sep 27, 2026
Total Debt to Equity (MRQ)
1.87x
vs Capital Markets peers
Updated Sep 27, 2026
Current Ratio (MRQ)
1.50x
vs Capital Markets peers
Updated Sep 27, 2026
Book Value per Share (MRQ)
9.36USDUpdated Sep 27, 2026
Total Assets
11.35BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
8.52BUSDFY2025 · Dec 31, 2025
Total Liabilities
8.31BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
2.83BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.00BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
5.31BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.25BUSDFY2025 · Dec 31, 2025
Other Short-term Investments
1.70BUSDFY2025 · Dec 31, 2025
Accounts Receivable
34.01MUSDFY2025 · Dec 31, 2025
Accounts Payable
17.57MUSDFY2025 · Dec 31, 2025
Short-term Debt
2.84BUSDFY2025 · Dec 31, 2025
Deferred Revenue
441.00KUSDFY2025 · Dec 31, 2025
Other Current Liabilities
125.54MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.50BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
111.94MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
192.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
342.92MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.03BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
16.43USDUpdated Sep 27, 2026
52-Week High
45.92USDUpdated Sep 27, 2026
52-Week Change
-29.31%
vs all stocks
Updated Sep 27, 2026
Beta
3.68x
vs all stocks
Updated Sep 27, 2026
50-Day MA
23.10USDUpdated Sep 27, 2026
200-Day MA
25.00USDUpdated Sep 27, 2026
Avg 10-Day Volume
5.22MSharesUpdated Sep 27, 2026
Avg 30-Day Volume
5.51MSharesUpdated Sep 27, 2026
Diluted EPS (TTM)
-0.4300USDUpdated Sep 27, 2026
Other Income / Expense
-786.54MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is -0.1%, lower than 95% of its Capital Markets peers (median 67.3%)Significant